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Abstract Von Willebrand factor (vWF) is an essential multi-
meric protein for adhesion of platelets to an injured vessel wall.
Endothelial cells secrete vWF by either a constitutive or a
regulated pathway. It is unknown whether the secretory
partitioning of vWF is dependent on the level of vWF synthesis.
We employed the widely applied tetracycline-controlled transac-
tivator system (tTA) to study the regulation of vWF mRNA
synthesis in stably transfected Madin Darby kidney (MDCK-II)
cells in a quantitative manner. Immunofluorescence staining with
anti-vWF antibodies revealed that increasing the concentration
of tetracycline resulted in a decreased number of MDCK-II cells
that synthesize vWF. Apparently, tTA-regulated gene expression
in an individual cell functions as an `on/off' system rather than
regulating the level of gene expression in a dose-response
manner, as reported previously.
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1. Introduction
Von Willebrand factor (vWF) is a large multimeric glyco-
protein that plays an essential role in hemostasis. It primarily
acts as a `molecular bridge' that connects the platelet to the
subendothelium, exposed upon injury of the vessel wall. The
biosynthesis of vWF is restricted to two cell types, i.e. the
endothelial cell and the megakaryocyte. In the endothelial
cell, vWF that exits the trans-Golgi network is routed by
two di¡erent pathways, denoted the constitutive and the regu-
lated pathway (reviewed in [1]). Secretion by the latter path-
way is typi¢ed by storage of vWF in endothelial cell-speci¢c
organelles (Weibel-Palade bodies) and release upon activation
with an appropriate agonist. Constitutively secreted vWF con-
sists of dimers and low molecular weight multimers, whereas
vWF released from the Weibel-Palade bodies is contained in
high molecular weight multimers. The latter species are par-
ticularly e¡ective ligands for platelet adhesion [2]. At present,
factors or conditions that determine the secretory partitioning
of vWF (at di¡erent levels of expression) are unknown,
although it has been hypothesized that for the secretion of
hormones the constitutive route may represent a default path-
way, operative when the regulated pathway is `saturated' [3].
To study this issue, we used a system that is widely em-
ployed to regulate protein synthesis in cultured cells and in
transgenic mice by varying the corresponding mRNA synthe-
sis [4]. This regulatory system exploits the sensitivity of mam-
malian cells for the bacterial antibiotic tetracycline (tet) as
well as their ability to functionally synthesize the prokaryotic
tet repressor. The tet repressor has been converted into a
eukaryotic transactivator by fusion with the activator domain
of virion protein 16 (VP16) of the Herpes Simplex virus type 1
(denoted the tet-controlled transactivator or tTA). This pro-
tein stimulates transcription initiated at a promoter, derived
from human cytomegalovirus (CMV). The enhancer region of
this promoter has been removed and substituted by eight con-
secutive tet operator sequences. In the absence of tTA, this
`minimal promoter' is virtually inactive. HeLa cells, which
constitutively express tTA and are stably transfected with
DNA encoding luciferase, preceded by the minimal CMV
promoter, synthesize a high level of luciferase. The stimula-
tion of luciferase expression by tTA can be gradually reduced
by administration of tet which interferes with the binding of
tTA to the tet operators. It is assumed that tTA provides for a
tightly controlled gene expression system in which the level of
expression in each cell is a direct consequence of the tet con-
centration [4].
Here, we employed the tTA system to regulate vWF syn-
thesis in Madin Darby kidney cells that had been stably trans-
fected with vWF cDNA and that constitutively express tTA
(MDCK-II/vWF). MDCK-II cells lack endogenous vWF ex-
pression, but are able to secrete vWF both by a constitutive
and by a regulated pathway upon transfection with vWF
cDNA [5]. The data con¢rm that the tet concentration deter-
mines the level of vWF expression of a population of cells as
has been reported before [4]. However, inspection of individ-
ual cells by immuno£uorescence demonstrated that the level
of vWF synthesis of the cell population is a re£ection of the
number of cells that produce vWF rather than the resultant of
an identical, de¢ned level of expression of each individual cell.
2. Materials and methods
2.1. Plasmids
Plasmids pUHD15-1 (containing the tTA gene), pUHD13-3 (con-
taining the minimal promoter and the luciferase reporter gene) and
pUHD10-3 (containing the minimal promoter and a multiple cloning
site) were kindly provided by Dr. H. Bujard (Center of Molecular
Biology, University of Heidelberg, Heidelberg, Germany). Plasmid
p-hd (containing the hygromycin resistance gene) was kindly provided
by Dr. B. Grinnell (Lilly Corp., Indianapolis, IN, USA). VWF
cDNA, obtained by digestion of pSVL-vWF DNA [6] with EcoRI,
was ligated into EcoRI-digested pUHD10-3 DNA, yielding pUHD10-
3-vWF.
2.2. Tissue culture
MDCK-II cells were cultured in Iscove's modi¢cation of Eagle's
medium, supplemented with penicillin (100 U/ml), streptomycin (100
Wg/ml), fungizone (0.25 Wg/ml) and 10% (v/v) fetal calf serum (FCS).
The cells were split twice a week (surface dilution 1:4) using trypsin to
suspend the cells. Cells were kept at 37³C in a moist atmosphere in a
5% CO
2
/95% air incubator.
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2.3. Luciferase assay
Cell extracts were prepared and assayed for luciferase activity as
described [7] using a Luminat LB 9501 illuminometer (Berthold).
2.4. Immuno£uorescence
The procedure to visualize vWF protein, using a 1:500 dilution of
rabbit polyclonal anti-vWF serum (Dakopatts) as the ¢rst antibody
and a 1:300 dilution of Cy-3-conjugated goat anti-rabbit antiserum
(Jackson Immuno Research Lab.) as the second antibody, has been
described before [6]. The cells were viewed with an Olympus IMT2
£uorescence microscope.
2.5. RNA isolation and Northern blotting
Total RNA of various cell lines was isolated with Trizol reagent,
according to the manufacturer's instructions (Gibco Life Technologies
Inc.). Northern blotting of 10 Wg of RNA was essentially done as
described [8]. A 490 bp BamHI-HindIII vWF cDNA fragment, radio-
labelled with the random primer DNA labeling system (Gibco Life
Technologies Inc.) and K-[
32
P]dATP, was used as a probe for
RNA:DNA hybridization. Non-incorporated radioactivity was re-
moved by Sephadex G-50 chromatography. After hybridization, ra-
dioactive probes were removed by incubating the blots twice for 20
min at 90³C in 0.1USSC, 0.1% (w/v) SDS, 1% (w/v) sodium pyro-
phosphate. Subsequently, the blots were reutilized for hybridization
with a radiolabelled 89 bp EcoRI-SalI cDNA fragment of glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) for calibration of the
amount of RNA applied.
3. Results
3.1. Stable integration of pUHD15-1 in MDCK-II cells
To obtain MDCK-II cells that constitutively express tTA,
we cotransfected pSV2neo (carrying the neomycin resistance
(neo
R
) gene) with a molar excess of pUHD15-1 DNA (encod-
ing tTA) [9]. Thirty neo
R
clones were isolated of which 22
survived prolonged growth in a G418-containing medium.
To verify whether these clones contain stably integrated tTA
cDNA that encodes functionally active tTA protein, a tran-
sient transfection with pUHD13-3 was performed. This plas-
mid contains DNA, encoding luciferase, coupled to the min-
imal CMV promoter. Subsequently, luciferase activity was
measured in extracts of neo
R
cells. Nine extracts displayed
luciferase levels that were 7^40-fold higher than untransfected
MDCK-II cells (Fig. 1). In addition, the same experiment was
performed in the presence of a high concentration of tet (1 Wg/
ml). At this concentration of the antibiotic, the luciferase syn-
thesis was reduced in extracts of each clone. However, a re-
duction of luciferase activity in the presence of 1 Wg/ml tet to
background levels of untransfected cells was observed in only
three cases. These three clones, denoted MDCK-II-V9,
MDCK-II-V20 and MDCK-II-V25, were selected for further
analysis. A similar transient transfection experiment, at vari-
ous tet concentrations, showed that clone MDCK-II-V25 dis-
plays the highest activity in the absence of tet, whereas under
these conditions MDCK-II-V20 produced approximately half
the amount of luciferase per cell and MDCK-II-V9 about
25%, relative to MDCK-II-V25 (Fig. 2). Clearly, in the pres-
ence of 0.1 Wg/ml tet the expression of luciferase in each of
these clones is reduced to background levels.
3.2. Stable integration of pUHD10-3-vWF in MDCK-II-V25
MDCK-II-V25 cells were used for the stable integration of
vWF cDNA, preceded by the minimal CMV promoter. A
cotransfection was performed with p-hd (carrying the hy-
gromycin resistance gene (hyg
R
)) and an excess of plasmid
pUHD10-3-vWF [9]. Twenty hyg
R
clones were isolated and
14 survived prolonged growth in selective medium. Analysis
of vWF expression was performed by immuno£uorescence,
revealing that eight clones displayed both perinuclear vWF
staining and a punctate £uorescence pattern, representing
storage organelles as shown before [5]. Two clones that dis-
play the most extensive vWF staining, denoted MDCK-II-
V25.59 and MDCK-II-V25.66, were selected for further anal-
ysis.
3.3. Analysis of vWF mRNA levels at di¡erent tet
concentrations
The amount of vWF mRNA levels of MDCK-II-V25.59
cells, cultured at di¡erent tet concentrations, was determined
by Northern blotting and phosphorimager analysis. To that
end, total RNA was isolated from cells cultured grown until
con£uency in the presence of the indicated tet concentrations
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Fig. 1. Luciferase activity of various MDCK-II-tTA cell lines after
transient transfection with plasmid pUHD13.3. Luciferase activity
was measured in extracts of various MDCK-II-tTA cell lines and
control MDCK-II cells (C) that were transiently transfected with
pUHD13.3 DNA, containing DNA encoding luciferase that is pre-
ceded by the minimal CMV promoter. The cells were cultured in
the absence (3) or presence (+) of 1 Wg/ml tet. RLU: relative light
unit.
Fig. 2. Luciferase activity of selected MDCK-II-tTA cell lines after
transient transfection with pUHD13.3 cultured at di¡erent tet con-
centrations. Luciferase activity was measured in extracts of the
MDCK-II-tTA cell lines, MDCK-II-V25, MDCK-II-V20 and
MDCK-II-V9, and in extracts of control MDCK-II cells (C) that
were each transiently transfected with pUHD13.3, containing DNA
encoding luciferase that is preceded by the minimal CMV promoter.
RLU: relative light unit.
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(Fig. 3). Clearly, the amount of vWF mRNA decreases upon
increasing tet concentration and has completely disappeared
in the presence of 20 ng tet/ml. By employing a vWF antigen-
speci¢c ELISA, we obtained virtually identical results for
vWF protein synthesis as a function of di¡erent tet concen-
trations (data not shown).
3.4. Immuno£uorescence analysis of vWF expression by
MDCK-II-V25.59 and MDCK-II-V25.66 cells
The experiments described above allow two interpretations:
(1) each individual cell expresses vWF at a level corresponding
to the tet concentration, (2) the tet concentration determines
the number of cells participating in vWF synthesis. To dis-
criminate between these two options, we inspected individual
cells by immuno£uorescence to analyze vWF expression by
cultured MDCK-II-V25.59 and MDCK-II-V25.66 cells at dif-
ferent tet concentrations (Fig. 4A). Furthermore, the number
of immuno£uorescent cells was precisely counted and plotted
against the tet concentration employed (Fig. 4B). The data
clearly show that the number of immuno£uorescent cells is
reduced upon increasing the tet concentration. To analyze
the correlation between the number of immuno£uorescent
cells at a particular tet concentration and the amount of
vWF mRNA, the data on the amount vWF mRNA synthe-
sized as a function of the tet concentration (see Fig. 3) were
combined with those obtained on the number of immuno-
£uorescent cells at the same tet concentration (Fig. 5). This
¢gure demonstrates a precise correlation between the number
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Fig. 3. Northern blotting of RNA isolated from cell line MDCK-II-V25.59, cultured at di¡erent tet concentrations. A: Lanes 1^10: Autoradio-
gram of the Northern blot of MDCK-II-V25.59 RNA, cultured at the indicated tet concentrations. A 490 bp fragment of vWFcDNA was used
as a probe. B: Results obtained by phosphorimaging of the bands shown in (A), corrected for the di¡erences in RNA amounts as determined
by probing with a 89 bp fragment of GAPDH cDNA. PIU: phosphorimager unit.
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of cells that display vWF expression and the amount of vWF
mRNA that is synthesized at di¡erent tet concentrations.
4. Discussion
In the present study, we attempted to exploit the tetracy-
cline-controlled transactivator (tTA) system to address the
following issue: is the distribution of vWF between the two
distinct secretory pathways a¡ected by its level of expression?
Obviously, we did not resolve this issue due to unexpected
¢ndings on the mechanism of the widely employed tTA sys-
tem to regulate gene expression. Our data actually contradict
the view that regulation of gene expression by the transacti-
vator tTA in an individual cell occurs in a gradual mode that
is dependent on the tet concentration employed. The original
concept assumes that the level of tTA-dependent gene expres-
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Fig. 4. The number of £uorescent MDCK-II-V25.59 cells, cultured at various tet concentrations. MDCK-II-25.59 cells were grown on cover-
slips until con£uency at the indicated tet concentrations. A: Immuno£uorescence for vWF and phase contrast analysis of di¡erent sectors of
cells. B: The percentage of vWF-expressing cells per sector was determined and plotted against the tet concentration.
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sion is dependent on the tet concentration, administered to the
cells [4]. However, our data obtained with MDCK-II cells that
constitutively express tTA and that have been stably trans-
fected with vWF cDNA, provided with the minimal CMV
promoter, indicate that tTA-driven gene expression in a cul-
tured cell is either fully operational (in the absence of tet) or
completely repressed (in the presence of a de¢ned threshold
concentration of tet). Hence, under these conditions a gradual
variation of the tet concentration does not allow for concom-
itant variation of the level of gene expression per cell. Analysis
of a population of MDCK-II/vWF cells by immuno£uores-
cence rather shows that administration of an increasing con-
centration of tet results in a decreased number of cells that
participate in tTA-driven vWF synthesis. At present, a ration-
ale for these observations is not readily available. It has been
argued that the entry of the antibiotic into mammalian cells
would be only dependent on passive di¡usion through the cell
membrane, in contrast to the entry in bacteria that occurs
both by an active energy-dependent transport system and by
passive di¡usion [10]. If passive di¡usion of tet into mamma-
lian cells were the only mode of entrance then we assume that
at low tet concentrations only a small fraction of these clonal
MDCK-II cells is susceptible to tet, possibly due to a partic-
ularly sensitive phase in the cell cycle. In that case, the sensi-
tivity of other phases of the cell cycle apparently requires a
higher dose of the antibiotic.
The signi¢cance of the tetracycline-controlled transactivator
system clearly goes beyond studies to regulate gene expression
in cultured cells. At present, the tTA system is widely em-
ployed to study temporal regulation of gene expression in
transgenic mice by either providing or withdrawing tet from
the diet of these animals [11^13]. An extrapolation of the data
reported in this study to the e¡ect of decreasing concentra-
tions of tet in the diet of transgenic mice, having a transgene
under the control of tTA, would imply that an increasing
number of cells would participate in the synthesis of the trans-
genic protein rather than a gradually increased mRNA and
protein synthesis. The ultimate result for proteins delivered to
the bloodstream would be similar, irrespective of the mecha-
nism by which tet controls tTA-driven synthesis. However, in
the case of an intracellular transgene under the control of tTA
our data would predict a mosaic expression pattern dependent
on the concentration of the antibiotic supplied.
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Fig. 5. Comparison between the number of vWF-expressing cells
and the vWF mRNA levels of MDCK-II-V25.59 cells, cultured at
various tet concentrations. The cells were grown in 56 cm
2
Petri
dishes until con£uency in medium, provided with the indicated tet
concentrations. RNA was isolated and used for Northern blotting
as described in Section 2. MDCK-II-25.59 cells were grown on cov-
erslips until con£uency at the indicated tet concentrations. Immuno-
£uorescence was performed and the number of £uorescent cells was
counted per ¢eld. Both values, from the Northern blotting as well
as the counted £uorescent cells, were plotted against the tet concen-
tration as a percentage of the values in the absence of the antibiot-
ic.
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